Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign

[Figure: see text]

Detalles Bibliográficos
Autores principales: Wambier, Carlos Gustavo, Vaño-Galván, Sergio, McCoy, John, Pai, Suraj, Dhurat, Rachita, Goren, Andy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by the American Academy of Dermatology, Inc. 2020
Materias:
JAAD Online
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387285/
https://www.ncbi.nlm.nih.gov/pubmed/32735970
http://dx.doi.org/10.1016/j.jaad.2020.07.099
_version_ 1783564090644365312
author Wambier, Carlos Gustavo
Vaño-Galván, Sergio
McCoy, John
Pai, Suraj
Dhurat, Rachita
Goren, Andy
author_facet Wambier, Carlos Gustavo
Vaño-Galván, Sergio
McCoy, John
Pai, Suraj
Dhurat, Rachita
Goren, Andy
author_sort Wambier, Carlos Gustavo
collection PubMed
description [Figure: see text]
format Online
Article
Text
id pubmed-7387285
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher by the American Academy of Dermatology, Inc.
record_format MEDLINE/PubMed
spelling pubmed-73872852020-07-29 Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign Wambier, Carlos Gustavo Vaño-Galván, Sergio McCoy, John Pai, Suraj Dhurat, Rachita Goren, Andy J Am Acad Dermatol JAAD Online [Figure: see text] by the American Academy of Dermatology, Inc. 2020-12 2020-07-29 /pmc/articles/PMC7387285/ /pubmed/32735970 http://dx.doi.org/10.1016/j.jaad.2020.07.099 Text en © 2020 by the American Academy of Dermatology, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle JAAD Online
Wambier, Carlos Gustavo
Vaño-Galván, Sergio
McCoy, John
Pai, Suraj
Dhurat, Rachita
Goren, Andy
Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
title Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
title_full Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
title_fullStr Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
title_full_unstemmed Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
title_short Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
title_sort androgenetic alopecia in covid-19: compared to age-matched epidemiologic studies and hospital outcomes with or without the gabrin sign
topic JAAD Online
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387285/
https://www.ncbi.nlm.nih.gov/pubmed/32735970
http://dx.doi.org/10.1016/j.jaad.2020.07.099
work_keys_str_mv AT wambiercarlosgustavo androgeneticalopeciaincovid19comparedtoagematchedepidemiologicstudiesandhospitaloutcomeswithorwithoutthegabrinsign
AT vanogalvansergio androgeneticalopeciaincovid19comparedtoagematchedepidemiologicstudiesandhospitaloutcomeswithorwithoutthegabrinsign
AT mccoyjohn androgeneticalopeciaincovid19comparedtoagematchedepidemiologicstudiesandhospitaloutcomeswithorwithoutthegabrinsign
AT paisuraj androgeneticalopeciaincovid19comparedtoagematchedepidemiologicstudiesandhospitaloutcomeswithorwithoutthegabrinsign
AT dhuratrachita androgeneticalopeciaincovid19comparedtoagematchedepidemiologicstudiesandhospitaloutcomeswithorwithoutthegabrinsign
AT gorenandy androgeneticalopeciaincovid19comparedtoagematchedepidemiologicstudiesandhospitaloutcomeswithorwithoutthegabrinsign

Ejemplares similares